What is the main business of Ośrodek Badań Klinicznych Labmed?

The main business activity of Ośrodek Badań Klinicznych Labmed focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 12, 2024.

Where is the headquarters located?

The headquarters is located at: ul. Adama Asnyka 9F, 71-526 Szczecin.

Who is on the management board?

The management board consists of: Agnieszka Karczmarczyk (Member of the Management Board) and Filip Karczmarczyk (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 11, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $26,579 in 2024.

Yes, in 2024 the company achieved a net profit of $19,780.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $5,751 in 2024, representing 85% of all operating expenses.

Ośrodek Badań Klinicznych Labmedsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-01-12

Share capital

10 000,00 PLN

Activity description

Ośrodek Badań Klinicznych Labmed is a medical facility that provides free long-term cardiology care, including diagnostics, treatment, and consultations for heart and circulatory diseases. They offer regular free laboratory tests, such as blood and urine analyses, and facilitate participation in clinical trials to improve patient health outcomes. The laboratory is staffed by experienced diagnosticians who collect samples and address patient inquiries.

Registered address

ul. Adama Asnyka 9F, 71-526 Szczecin, Poland

Website

labmed.biz.pl

Phone

Electronic delivery address

AE:PL-62091-92358-WRDHD-19

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 147.65kMedianUSD 72.17kAverageUSD 3.11m

Net profit

This companyUSD 5.93kMedianUSD 69.14AverageUSD 80.67k

Operating costs

This companyUSD 136.02kMedianUSD 75.48kAverageUSD 2.93m

Assets

This companyUSD 348.16kMedianUSD 121.09kAverageUSD 3.89m

Industry

Bank accounts

Registered as a VAT taxpayer on 2024-02-01. Active

Bank Pekao SA
22 1240 3813 1111 0011 3439 9345
Bank Pekao SA
27 1240 3813 1978 0011 3439 9361

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Oct 14, 2025	Regional investment aid	$58,222$58,222	Szczeciński Fundusz Pożyczkowy sp. z o.o.

Tenders

No recorded participation in tenders.

Authorized Representatives

Agnieszka Karczmarczyk – Management Board Member

Filip Karczmarczyk – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Agnieszka Karczmarczyk (59)	50	$1,350.62	50%
Filip Karczmarczyk (36)	50	$1,350.62	50%

Agnieszka Karczmarczyk and Filip Karczmarczyk hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Competitors

	Name	Revenue	Website
	CBK Med Clinicsp. z o.o.	$91,889.00	cbkmedclinic.pl
	Edoktor24 Servicessp. z o.o.	$34,089.64	edoktor24.pl

FAQ

Last updated: 2026-06-24